A seller-side lawyer I respect called me a few weeks ago to argue, in the friendly way these calls usually go, that the 12-month survival clause on the deal he was working would foreclose any fraud claim the buyer could conceivably bring after closing. The cap was tight, the survival was short, and the integration language was airtight. He had drafted a wall.
I told him the wall was lower than he thought. In Delaware, in 2025 and 2026, a survival clause cannot eliminate a fraud claim that targets the contract itself. The Chancery has said so plainly and more than once. A seller who treats the survival clause as the end of the conversation is leaving live exposure on the table — and, more importantly, often missing the drafting move that would actually do the work.
The survival fight is one of the most lawyered and least understood corners of a private acquisition agreement. It also happens to be one of the corners where the doctrine has moved meaningfully in the last eighteen months. The drafters who are still pulling forms from 2022 are pulling forms the Chancery has already disagreed with.
The Chancery has drawn a hard line on contractual fraud
The doctrinal starting point is well-settled. A representation in an acquisition agreement is a contract term. A breach of that representation gives rise to a contract claim that, in Delaware, can be controlled by the parties — through survival periods, baskets, caps, exclusive-remedy provisions, and the usual menu. The seller’s lawyer who builds a tight survival wall is doing the job the form contemplates.
The fraud claim is a different animal. A common-law fraud claim, in Delaware, requires a knowing misrepresentation, scienter, reliance, and damages. The Chancery has been emphatic that public policy bars a seller from using the contract itself — the very document containing the alleged false statement — to release itself from a fraud claim based on that statement. The agreement cannot be both the instrument of the fraud and the seller’s shield against the fraud.
That has been the Chancery’s view since the early Abry Partners line. The 2025 cases tighten it. The Chancery now treats survival clauses as binding on contractual breach claims and not binding on fraud claims that target the same reps. A 12-month survival does not give the seller 12 months of fraud exposure; it gives the seller 12 months of contract-breach exposure plus the full statute of limitations on the fraud claim. The numbers are different and the seller’s risk profile is different.
The May 2025 American Bar Association commentary in Business Law Today put the point cleanly when it observed that Delaware’s contractarianism has limits where forfeiture of fraud claims is concerned. The Court of Chancery, as the ABA piece walks through, has repeatedly declined to let survival mechanics swallow a fraud claim the buyer would otherwise have. A drafter who reads the form contract and thinks the survival clause is doing the work needs to read the case law and discover it is not.
The seller’s actual lever is anti-reliance, not survival
If the survival clause cannot eliminate the fraud claim, what can? The answer is a different clause entirely. Delaware permits a seller to bar extra-contractual fraud claims through a properly drafted anti-reliance provision — that is, a clause that affirmatively states the buyer did not rely on any representations other than those expressly set out in the agreement. The Chancery has insisted, going back to Anvil Holding and refined through Prairie Capital and the more recent Online HealthNow line, that the clause has to be explicit. Boilerplate integration language will not do. A generic merger clause will not do. The contract has to say, in substance, that the buyer is relying on the agreement’s reps and only those reps, and that the buyer disclaims reliance on every other communication, document, projection, and statement made anywhere outside the four corners.
A clause drafted that way will eliminate the extra-contractual fraud claim — the claim that the seller lied in the management presentation, in the data room, in a side conversation between the bankers, in the projections deck. That is a significant carve-out and most middle-market frauds live there, not in the four corners of the agreement.
What the anti-reliance clause cannot do, under any Delaware drafting trick I have seen survive a motion to dismiss, is eliminate a fraud claim based on the reps themselves. If the seller knowingly told a lie inside Section 3.10 of the merger agreement, the seller is exposed to a fraud claim on that lie regardless of how tight the survival clause is and regardless of how aggressive the anti-reliance language is. The Chancery treats that as a public-policy floor. Delaware will not enforce a contract that purports to release a party from intentional fraud committed in the contract itself.
That public-policy floor is the one I find sellers’ lawyers most surprised by. The integration clauses are familiar. The anti-reliance language is becoming familiar. The hard rule that the seller cannot, by any drafting mechanism, eliminate a fraud claim on the contractual reps themselves — that rule is doctrinally clean and practically uncomfortable.
What the seller can do is cap the fraud damages — carefully
The Chancery has been more permissive on damages than on liability. A seller cannot extinguish a contractual-fraud claim, but the Chancery has, in several cases, enforced caps and remedy limitations that affect what the buyer can recover when the fraud claim succeeds. The doctrinal frame is that the contract cannot bar the claim, but can limit the recovery, provided the limitation does not amount to a constructive bar.
The drafting space that opens is narrow but real. A seller can negotiate a damages cap that applies to the fraud claim, provided the cap is not so low as to amount to a release. A seller can require pre-suit notice and good-faith negotiation periods, provided they do not function as a forfeiture trigger. A seller can specify the measure of damages, the exclusion of consequential damages outside fraud, and the procedural posture of the claim. None of those moves eliminate the claim. All of them constrain it.
I tell seller-side clients three things about the damages architecture. First, a fraud-damages cap should be drafted as a cap and not as an exclusive remedy. The Chancery has been skeptical of exclusive-remedy provisions in the fraud context and the safer drafting move is to leave the remedy theoretically open while constraining the dollar amount. Second, the cap should be large enough to look like a real allocation of risk and not like a release in cap clothing. Half the deal value is usually defensible. Five percent of deal value typically is not. Third, the consequential-damages exclusion should be drafted with a fraud carve-out the seller can live with — the standard form’s broad exclusion often does not survive scrutiny when the fraud claim runs through it.
The middle path most agreements should land on
When I am running drafting from the seller’s side on a Delaware-governed deal, the survival fight is no longer where I spend the most time. Twelve months is the post-closing window for contract-breach claims and the buyer’s side will live with it on a clean deal. The real work is in the three places the Chancery has told us actually move the analysis.
The first is the anti-reliance clause. It needs to be specific, comprehensive, and explicitly waive reliance on every category of communication outside the agreement. The clause should name the categories — management presentations, projections, financial models, data-room contents, oral statements by named persons — and disclaim reliance on each. The buyer’s negotiating instinct is to fight every category. The seller’s job is to push hard on each one because a clause that names everything and disclaims everything is the clause the Chancery will enforce.
The second is the fraud-definition clause. Most agreements define fraud loosely or not at all. A defined-term Fraud with a clean Delaware-law scienter requirement — knowing, intentional, with reliance — narrows the universe of claims that can survive the survival clause to a manageable set. A fraud definition that drops the scienter requirement and adopts a broader negligent-misrepresentation standard is a gift to the buyer’s litigators.
The third is the damages cap on fraud claims, drafted as a cap rather than a release, sized to look like risk allocation, and paired with a consequential-damages exclusion that has a fraud carve-out the seller can defend. The deal-terms asymmetry on damages and remedy provisions shows up in nearly every middle-market post-closing dispute, and most of the leverage was decided at signing rather than at the post-closing meeting.
The survival fight is still worth having, but it is worth having for the contract-breach claims and not for the fraud claims. The seller who walks out of signing thinking the 12-month survival cleared the deck is walking into a fraud-claim landscape that, in 2026, is more buyer-friendly than the form contract suggests.
For sellers working through an M&A exit, the doctrinal background is worth at least a half-hour conversation with deal counsel before the survival clause gets re-papered to match a 2022 form. The Chancery has moved. The form has not always kept up.
If you are negotiating survival, anti-reliance, or fraud language on a pending Delaware-governed deal, feel free to reach out to my firm manager, Magda, at Magda@montague.law, or fill out our contact form. Mention you read this post.
— John
